Doximity (DOCS)
(Real Time Quote from BATS)
$28.98 USD
+0.49 (1.72%)
Updated Jun 6, 2024 02:10 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Doximity, Inc. [DOCS]
Reports for Purchase
Showing records 21 - 40 ( 77 total )
Company: Doximity, Inc.
Industry: Medical Services
The Final Cut? Large Reset Puts Next Year Into Focus as Company Adapts to Evolving Customer Demand
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
F1Q Beat but FY Guidance Lowered by ~8%; Headcount Reductions in Place
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Investor Day Takeaways; Focus on AI and Clinical Utilization to Drive Increased Commercialization
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Weak F1Q Guide on Ongoing New Product Launch Delays; Remain Below Consensus Looking Out
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
Company: Doximity, Inc.
Industry: Medical Services
F4Q Slight Profit Beat; F1Q Guidance Falls Short of Consensus and Sets Up for Challenging Ramp for FY Outlook
Provider: KeyBanc Capital Markets
Analyst: Research Department